Sigma-tau Industrie Farmaceutiche Riunite S.p.a.

Fiat Auto S.p.a.

Seuref A.g.

Schering Spa

Italfarmaco, Sa

Alberto Bertelli

Carmelo Benedetto

A convertible automobile in which the body is provided with a housing having a cover element and located to the rear of a pair of seats in proximity to the rear axle, and with a roof panel connecting the windscreen to the rear window; the roof panel, the windscreen, the rear window and the body define the automobile passenger compartment; the roof panel and the rear window are two rigid elements which are separated from each other and are mobile between a position in which they define the passenger compartment roof and a position in which the passenger compartment is uncovered. The roof panel and rear window remain connected to the body of the automobile during each stage of the uncovering of the automobile and of their positioning in the housing.

Convertible automobile

The invention relates to novel pharmaceutical compositions containing ubiquinone, particularly Coenzyme Q.sub.10, and mixtures of phospholipids having organic or vegetal origin, in weight-ratios ranging from 1/1 to 1/100,000, together with pharmaceutically acceptable excipients. The pharmaceutical compositions of the invention are useful in the treatment of pathological conditions related to insufficient cerebral perfusion, atherosclerosis or enzymatic impairments involving cerebral metabolic deficiencies, and generally in conditions deriving from cerebral and tissular postanoxy. Said pharmaceutical composition allows a better absorption of Coenzyme Q.sub.10.

Pharmaceutical compositions having cerebral antianoxic and metabolic

The present invention refers to new pharmaceutical compositions which contain Coenzyme Q.sub.10 in amounts from 0.0001 to 10%, dissolved or suspended in a suitable vehicle and which are useful in the pharmaceutical and cosmethological field for the topical cutaneous treatment of skin diseases and for the prophylaxis of dystrophias or dysmetabolic conditions of the cutis.

Pharmaceutical formulations containing coenzyme Q.sub.10 suitable for

A new salt of the macrolide antibiotic Josamycin with (-)-cis-1,4-epoxypropionylphosphonic acid, of formula (I) ##STR1## The salt (I), prepared from Josamycin base and phosphomycin, possesses favorable antimicrobial and pharmacokinetics properties.

Epoxypropylphosphonate salt of jesamycin and pharmaceutical composition

The invention relates to a pharmaceutical composition containing carnitine or acetylcarnitine and Coenzyme Q.sub.10 in ratios from 100:1 to 2:1, together with pharmaceutically acceptable eccipients. The pharmaceutical composition described is suitable for the treatment of tissue energetic and metabolic disorders, and especially of heart and blood vessels, occurring in atherosclerosis, in myocardial or coronaric insufficiency, in hypertension, in cerebral ischaemia and, in general, tissue anoxia.

Growing community of inventors

Milan, Italy

Alberto Bertelli